TQB2450 with or Without Anlotinib As Maintenance Treatment in Subjects with Locally Advanced/unresectable Non-Small Cell Lung Cancer That Have Not Progressed after Prior Concurrent/sequential Chemoradiotherapy (R-ALPS): Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial